| Literature DB >> 32769059 |
Jiangcheng Shi1, Chengqing Hu1, Yuan Zhou1, Chunmei Cui1, Jichun Yang2, Qinghua Cui3.
Abstract
Physiological and pathophysiological differences widely exist in paired organ systems. However, the molecular basis for these differences remains largely unknown. We previously reported that there exist differentially expressed miRNAs (DEMs) in the left and right kidneys of normal mice. Here, we identified the DEMs in the left and right eyes, lungs, and testes of normal mice via RNA sequencing. As a result, we identified 26 DEMs in eyes, with 23 higher and 3 lower in the left eyes compared with right eyes; 21 DEMs in lungs, with 15 higher and 6 lower in the left lungs compared with right lungs; and 54 DEMs in testes, with 6 higher and 48 lower in the left testes compared with right testes. Ten microRNAs (miRNAs) were further examined by quantitative PCR assays, and seven of these were confirmed. In addition, correlation analysis was performed between paired organ miRNA expressions and diverse body fluid miRNA expressions. Finally, we explored the functions and networks of DEMs and performed biological process and pathway enrichment analysis of target genes for DEMs, providing insights into the physiological and pathophysiological differences between the two entities of paired organs.Entities:
Keywords: bioinformatic analysis; gene profile; miRNA; paired organ
Year: 2020 PMID: 32769059 PMCID: PMC7347495 DOI: 10.1016/j.omtn.2020.07.006
Source DB: PubMed Journal: Mol Ther Nucleic Acids ISSN: 2162-2531 Impact factor: 8.886
Figure 1Heatmap of DEMs
Significantly DEMs between the left and right eyes, lungs, and testes.
Figure 2Validation of DEMs in the Paired Organ Systems of C57BL/6J Mice
(A–C) The expression levels of mmu-miR-142a-5p (A), mmu-miR-187-5p (B), and mmu-miR-203b-5p (C) in the eyes. (D–G) The expression levels of mmu-miR-100-3p (D), mmu-miR-107-5p (E), mmu-miR-122b-5p (F), and mmu-miR-148a-5p (G) in the lungs. (H and I) The expression levels of mmu-miR-204-5p (H) and mmu-miR-532-3p (I) in the testes. The data were normalized to the left organ (ns = 10–15; mean ± SEM). ∗p < 5e−2, versus left organ.
Figure 3Comparison of miRNA Expression Profiles in Paired Organs with miRNA Expression Profiles in Various Body Fluids
(A–I) Expression correlation between paired organ miRNAs and miRNAs in plasma (A), bile (B), and urine (C) of mice; homologous miRNAs in arterial plasma (D) and venous plasma (E) of rats; and homologous miRNAs in plasma (F), serum (G), bile (H), and urine (I) of humans. Asterisk indicates significant difference in correlation coefficients between miRNA expression profiles in the left and right lungs and miRNA expression profile in arterial plasma of rats (∗p < 5e−2), according to matched-pair t test.
Figure 4Functional Enrichment Analysis of the DEMs
(A–C) Enriched biological functions associated with the DEMs upregulated in the left eyes (A), left lungs (B), and right testes (C). The length of each bar is the value of −log10 (p value).
Figure 5Functional Similarity Network of the DEMs
(A–C) Each red/green node represents an upregulated miRNA in the left/right eye (A), the left/right lung (B), and the left/right testis (C), respectively.
Detailed Information for the Associations of miR-125a with Various Lung Diseases
| Lung Diseases | Evidence | PubMed Identifier (PMID) |
|---|---|---|
| Lung neoplasms | the results demonstrated that the panel of miRNA biomarkers (miR-125a-5p, miR-25, and miR-126) had the potential for the early detection of lung cancer; | |
| Non-small-cell lung carcinoma | these preliminary data suggest that serum miR-125a-5p, miR-145, and miR-146a may be useful noninvasive biomarkers for the clinical diagnosis of non-small-cell lung cancer | |
| Lung neoplasms | our results provide compelling evidence that miR-125a-5p, an epidermal growth factor-signaling-regulated miRNA, may function as a metastatic suppressor | |
| Non-small-cell lung carcinoma | hsa-miR-125a-5p was poorly expressed in lung cancer cells, and it could enhance lung cancer cell invasion by upregulating hsa-miR-125a-5p | |
| Lung neoplasms | miRNA hsa-miR-125a-3p activates p53 and induces apoptosis in lung cancer cells | |
| Non-small-cell lung carcinoma | hsa-miR-125a-5p could upregulate Rock-1 and enhance invasion in lung cancer cells | |
| Small-cell lung carcinoma | chemotherapy-regulated miRNA-125-HER2 pathway as a novel therapeutic target for trastuzumab-mediated cellular cytotoxicity in small-cell lung cancer | |
| Non-small-cell lung carcinoma | miR-125a-3p targets MTA1 to suppress non-small-cell lung cancer cell proliferation, migration, and invasion | |
| Lung carcinoma | miRNA-125a-5p plays a role as a tumor suppressor in lung carcinoma cells by directly targeting STAT3 | |
| Non-small-cell lung carcinoma | miR-125a-3p:Hsa-miR-125a-3p and hsa-miR-125a-5p are downregulated in non-small-cell lung cancer | |
| Non-small-cell lung carcinoma | we showed that, compared to adjacent non-neoplastic lung tissues, the expressions of miR-125a-5p and let-7e were decreased in lung adenocarcinomas and squamous-cell lung carcinomas samples | |
| Non-small-cell lung carcinoma | differential expression of miR-125a-5p and let-7e predicts the progression and prognosis of non-small-cell lung cancer | |
| Lung carcinoma | miRNA expression profiles of granulocytic myeloid-derived suppressor cells from mice bearing Lewis lung carcinoma |
Figure 6Target Analysis for the DEMs
(A–F) Biological process and pathway enrichment for target genes of the DEMs in the left (A) and right (B) eyes, left (C) and right (D) lungs, and left (E) and right (F) testes. The color of each point represents the value of −log10 (p value), and the different sizes of each point correspond to the number of genes represented in the term. The rich factor is the percentage of all the target genes found in the given ontology term.